350535 <common-name>2-[[(1s)-1-[4-[2-[5-(hydroxymethyl)-2-phenyl-1,3-oxazol-4-yl]ethoxy]phenyl]ethyl]-(4-methoxyphenoxy)carbonylamino]acetic acid</common-name> <description>2-[[(1s)-1-[4-[2-[5-(hydroxymethyl)-2-phenyl-1,3-oxazol-4-yl]ethoxy]phenyl]ethyl]-(4-methoxyphenoxy)carbonylamino]acetic acid is a compound with the formula C30H30N2O8. With an average molecular weight of 546.60 g/mol, 2-[[(1s)-1-[4-[2-[5-(hydroxymethyl)-2-phenyl-1,3-oxazol-4-yl]ethoxy]phenyl]ethyl]-(4-methoxyphenoxy)carbonylamino]acetic acid is a heavy molecule.</description> <cas>1807606-88-7</cas> <pubchem-id>118753087</pubchem-id> <chemical-formula>C30H30N2O8</chemical-formula> <weight>546.6</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T15:39:50Z</created-at> <updated-at type="dateTime">2026-08-31T15:39:50Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC(C1=CC=C(C=C1)OCCC2=C(OC(=N2)C3=CC=CC=C3)CO)N(CC(=O)O)C(=O)OC4=CC=C(C=C4)OC</moldb-smiles> <moldb-formula>C30H30N2O8</moldb-formula> <moldb-inchi>InChI=1S/C30H30N2O8/c1-20(32(18-28(34)35)30(36)39-25-14-12-23(37-2)13-15-25)21-8-10-24(11-9-21)38-17-16-26-27(19-33)40-29(31-26)22-6-4-3-5-7-22/h3-15,20,33H,16-19H2,1-2H3,(H,34,35)/t20-/m0/s1</moldb-inchi> <moldb-inchikey>XJGZYXFVUXQPSR-FQEVSTJZSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">546.2002159</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>4.3</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM346428</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>2-[[(1s)-1-[4-[2-[5-(hydroxymethyl)-2-phenyl-1,3-oxazol-4-yl]ethoxy]phenyl]ethyl]-(4-methoxyphenoxy)carbonylamino]acetic acid</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Oxazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0300840</sync-id> <structure-inchikey>XJGZYXFVUXQPSR-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>40040004000000000000802002000800000100100000000000000002000000000000001000000000200000000000002004000000000000000000000000000000100000000000000000000004000000000020800000000100000280009000000000040000010000010440000000004000000000000000000000001000000000000020010040000000800000000000008000800000020100000000001000010000000000000000000000000400080000000000000002080000000000000000000080000000000000000800000010000000000000000000000040400200000000000040001000000005040040000040000600000000000000000400000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAoAAAAKwAAAIABBgBgAAAAAQMGAGAAAAAD AQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEG QGgAAAADAwEIACgAAAADAgYAYAAAAAICBgBgAAAAAgIGQCgAAAADBAZAKAAA AAMECEAoAAAAAwIGQCgAAAADBAdAKAAAAAMDBkAoAAAAAwQGQGgAAAADAwEG QGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGAGAAAAACAggA YAAAAAEBBwAoAAAAAwMGAGAAAAACAgYAKAAAAAMECAAoAAAAAwIIAGgAAAAD AQEGACgAAAADBAgAKAAAAAMCCAAoAAAAAwIGQCgAAAADBAZAaAAAAAMDAQZA aAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBCAAoAAAAAwIGAGAA AAABAwsAAQABAgACA2gMAwRoDAQFaAwFBmgMBgdoDAUIIAgJAAkKAAoLAAsM aAwMDWgMDQ5oDA4PaAwOECAQEWgMERJoDBITaAwTFGgMFBVoDAwWABYXAAEY ABgZABkaABobKAIaHCAYHSAdHigCHR8gHyAgICFoDCEiaAwiI2gMIyRoDCQl aAwjJiAmJwAHAmgMDwtoDBUQaAwlIGgMQgQAAAAGAwQFBgcCBQwLDw4NBhES ExQVEAYhIiMkJSAXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:48:31Z</structure-indexed-at> </compound>